GILD Filing
4Filing Date: Jul 16, 2026

GILEAD SCIENCES, INC. (GILD) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001782135-26-000026open_in_new
Total Value$389.8K
Trades1
Insiders1

Transaction Details

Mercier Johanna
Chief Comm & Corp Aff Officer·Direct
Sell · Dispose
Common Stock
Shares-3.00K
Price$129.92
Total Value$389.8K
Shares Owned After121.23K
Transaction DateJul 15, 2026
10b5-1
Footnotes ▸

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. | Sale prices for the transactions reported range from $129.45 to $130.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Post-Transaction Holdings

Mercier Johanna
SecuritySharesChange
Common Stock121.23K-3.00K (-2.41%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-15 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: Mercier Johanna CIK: 0001782135 Role: Officer (Chief Comm & Corp Aff Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-15 | Code: S (Open market sale) Shares: -3,000 | Price: $129.92 Total Value: $389,757.60 Shares Owned After: 121,234 | Ownership: D (Direct) Footnotes: [F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. [F2] Sale prices for the transactions reported range from $129.45 to $130.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. --- Footnotes (Complete Index) --- F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2: Sale prices for the transactions reported range from $129.45 to $130.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. --- Signature --- /s/ /s/ Amy Kim by Power of Attorney for Johanna Mercier (2026-07-16)

keid analysis is for reference only and does not constitute investment advice.